TY - JOUR AU - Siegel, R. AU - Ma, J. AU - Zou, Z. AU - Jemal, A. PY - 2009 DA - 2009// TI - Cancer statistics, 2014. CA: a cancer journal for clinicians. 2014; 64(1):9–29. Ottaviani G, Jaffe N. The epidemiology of osteosarcoma JO - Cancer Treat Res VL - 152 UR - https://doi.org/10.1007/978-1-4419-0284-9_1 DO - 10.1007/978-1-4419-0284-9_1 ID - Siegel2009 ER - TY - JOUR AU - Bartel, D. P. PY - 2009 DA - 2009// TI - MicroRNAs: target recognition and regulatory functions JO - Cell VL - 136 UR - https://doi.org/10.1016/j.cell.2009.01.002 DO - 10.1016/j.cell.2009.01.002 ID - Bartel2009 ER - TY - JOUR AU - Inui, M. AU - Martello, G. AU - Piccolo, S. PY - 2010 DA - 2010// TI - MicroRNA control of signal transduction JO - Nat Rev Mol Cell Biol VL - 11 UR - https://doi.org/10.1038/nrm2868 DO - 10.1038/nrm2868 ID - Inui2010 ER - TY - JOUR AU - Schetter, A. J. AU - Leung, S. Y. AU - Sohn, J. J. AU - Zanetti, K. A. AU - Bowman, E. D. AU - Yanaihara, N. PY - 2008 DA - 2008// TI - MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma JO - JAMA VL - 299 UR - https://doi.org/10.1001/jama.299.4.425 DO - 10.1001/jama.299.4.425 ID - Schetter2008 ER - TY - JOUR AU - Yu, S. L. AU - Chen, H. Y. AU - Chang, G. C. AU - Chen, C. Y. AU - Chen, H. W. AU - Singh, S. PY - 2008 DA - 2008// TI - MicroRNA signature predicts survival and relapse in lung cancer JO - Cancer Cell VL - 13 UR - https://doi.org/10.1016/j.ccr.2007.12.008 DO - 10.1016/j.ccr.2007.12.008 ID - Yu2008 ER - TY - JOUR AU - Fulci, V. AU - Chiaretti, S. AU - Goldoni, M. AU - Azzalin, G. AU - Carucci, N. AU - Tavolaro, S. PY - 2007 DA - 2007// TI - Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia JO - Blood VL - 109 UR - https://doi.org/10.1182/blood-2006-12-062398 DO - 10.1182/blood-2006-12-062398 ID - Fulci2007 ER - TY - JOUR AU - Iorio, M. V. AU - Ferracin, M. AU - Liu, C. G. AU - Veronese, A. AU - Spizzo, R. AU - Sabbioni, S. PY - 2005 DA - 2005// TI - MicroRNA gene expression deregulation in human breast cancer JO - Cancer Res VL - 65 UR - https://doi.org/10.1158/0008-5472.CAN-05-1783 DO - 10.1158/0008-5472.CAN-05-1783 ID - Iorio2005 ER - TY - JOUR AU - Bao, Y. P. AU - Yi, Y. AU - Peng, L. L. AU - Fang, J. AU - Liu, K. B. AU - Li, W. Z. PY - 2013 DA - 2013// TI - Roles of microRNA-206 in osteosarcoma pathogenesis and progression JO - Asian Pac J Cancer Prev VL - 14 UR - https://doi.org/10.7314/APJCP.2013.14.6.3751 DO - 10.7314/APJCP.2013.14.6.3751 ID - Bao2013 ER - TY - JOUR AU - Tang, M. AU - Lin, L. AU - Cai, H. AU - Tang, J. AU - Zhou, Z. PY - 2013 DA - 2013// TI - MicroRNA-145 down-regulation associates with advanced tumor progression and poor prognosis in patients suffering osteosarcoma JO - Onco Targets Ther VL - 6 ID - Tang2013 ER - TY - JOUR AU - Huang, J. AU - Gao, K. AU - Lin, J. PY - 2014 DA - 2014// TI - MicroRNA-100 inhibits osteosarcoma cell proliferation by targeting Cyr61 JO - Tumor Biol VL - 35 UR - https://doi.org/10.1007/s13277-013-1146-8 DO - 10.1007/s13277-013-1146-8 ID - Huang2014 ER - TY - JOUR AU - Zhao, G. AU - Cai, C. AU - Yang, T. PY - 2013 DA - 2013// TI - MicroRNA-221 induces cell survival and cisplatin resistance through PI3K/Akt pathway in human osteosarcoma JO - PLoS One VL - 8 UR - https://doi.org/10.1371/journal.pone.0053906 DO - 10.1371/journal.pone.0053906 ID - Zhao2013 ER - TY - JOUR AU - Kota, J. AU - Chivukula, R. R. AU - O’Donnell, K. A. PY - 2009 DA - 2009// TI - Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model JO - Cell VL - 137 UR - https://doi.org/10.1016/j.cell.2009.04.021 DO - 10.1016/j.cell.2009.04.021 ID - Kota2009 ER - TY - JOUR AU - Cabrera, R. AU - Szabo, G. PY - 2013 DA - 2013// TI - Another armed CD4 + T cell ready to battle hepatocellular carcinoma JO - Hepatology VL - 58 UR - https://doi.org/10.1002/hep.26377 DO - 10.1002/hep.26377 ID - Cabrera2013 ER - TY - JOUR AU - Calin, G. A. AU - Croce, C. M. PY - 2006 DA - 2006// TI - MicroRNA signatures in human cancers JO - Nat Rev Cancer VL - 6 UR - https://doi.org/10.1038/nrc1997 DO - 10.1038/nrc1997 ID - Calin2006 ER - TY - JOUR AU - Liu, B. AU - Wu, X. AU - Liu, B. PY - 2012 DA - 2012// TI - MiR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN JO - Biochim Biophys Acta VL - 1822 UR - https://doi.org/10.1016/j.bbadis.2012.07.019 DO - 10.1016/j.bbadis.2012.07.019 ID - Liu2012 ER - TY - JOUR AU - Luzi, E. AU - Marini, F. AU - Sala, S. C. AU - Tognarini, I. AU - Galli, G. AU - Brandi, M. L. PY - 2008 DA - 2008// TI - Osteogenic differentiation of human adipose tissue-derived stem cells is modulated by the miR-26a targeting of the SMAD1 transcription factor JO - J Bone Miner Res VL - 23 UR - https://doi.org/10.1359/jbmr.071011 DO - 10.1359/jbmr.071011 ID - Luzi2008 ER - TY - JOUR AU - Xia, J. AU - Cheng, L. AU - Mei, C. AU - Ma, J. AU - Shi, Y. AU - Zeng, F. PY - 2014 DA - 2014// TI - Genistein inhibits cell growth andinvasion through regulation of miR-27a in pancreatic cancer cells JO - Curr Pharm Des VL - 20 UR - https://doi.org/10.2174/1381612820666140128215756 DO - 10.2174/1381612820666140128215756 ID - Xia2014 ER - TY - JOUR AU - Li, X. AU - Mertens-Talcott, S. U. AU - Zhang, S. AU - Kim, K. AU - Ball, J. AU - Safe, S. PY - 2010 DA - 2010// TI - MicroRNA-27a indirectly regulates estrogen receptor {alpha} expression and hormone responsiveness in MCF-7 breast cancer cells JO - Endocrinology VL - 151 UR - https://doi.org/10.1210/en.2009-1150 DO - 10.1210/en.2009-1150 ID - Li2010 ER - TY - JOUR AU - Zhao, X. AU - Yang, L. AU - Hu, J. PY - 2011 DA - 2011// TI - Down-regulation of miR-27a might inhibit proliferation and drug resistance of gastric cancer cells JO - J Exp Clin Cancer Res VL - 30 UR - https://doi.org/10.1186/1756-9966-30-55 DO - 10.1186/1756-9966-30-55 ID - Zhao2011 ER - TY - JOUR AU - Ma, Y. AU - Yu, S. AU - Zhao, W. AU - Lu, Z. AU - Chen, J. PY - 2010 DA - 2010// TI - MiR-27a regulates the growth, colony formation and migration of pancreatic cancer cells by targeting Sprouty2 JO - Cancer Lett VL - 298 UR - https://doi.org/10.1016/j.canlet.2010.06.012 DO - 10.1016/j.canlet.2010.06.012 ID - Ma2010 ER - TY - JOUR AU - Bao, Y. AU - Chen, Z. AU - Guo, Y. AU - Feng, Y. AU - Li, Z. AU - Han, W. PY - 2014 DA - 2014// TI - Tumor suppressor microRNA-27a in colorectal carcinogenesis and progression by targeting SGPP1 andSmad2 JO - PLoS One VL - 9 UR - https://doi.org/10.1371/journal.pone.0105991 DO - 10.1371/journal.pone.0105991 ID - Bao2014 ER - TY - JOUR AU - Miao, Y. AU - Li, J. AU - Qiu, X. AU - Li, Y. AU - Wang, Z. AU - Luan, Y. PY - 2013 DA - 2013// TI - MiR-27a regulates the self-renewal of the H446 small cell lung cancer cell line in vitro JO - Oncol Rep VL - 29 ID - Miao2013 ER - TY - JOUR AU - Pan, W. AU - Wang, H. AU - Jianwei, R. AU - Ye, Z. PY - 2014 DA - 2014// TI - MicroRNA-27a promotes proliferation, migration and invasion by targeting MAP2K4 in human osteosarcoma cells JO - Cell Physiol Biochem VL - 33 UR - https://doi.org/10.1159/000356679 DO - 10.1159/000356679 ID - Pan2014 ER - TY - JOUR AU - Croce, C. PY - 2012 DA - 2012// TI - Introduction to the role of microRNAs in cancer diagnosis, prognosis, and treatment JO - Cancer J VL - 18 UR - https://doi.org/10.1097/PPO.0b013e31825efb41 DO - 10.1097/PPO.0b013e31825efb41 ID - Croce2012 ER - TY - JOUR AU - Song, Q. C. AU - Shi, Z. B. AU - Zhang, Y. T. AU - Ji, L. AU - Wang, K. Z. AU - Duan, D. P. AU - Dang, X. Q. PY - 2014 DA - 2014// TI - Down-regulation of microRNA-26a is associated with metastatic potential and the poor prognosis of osteosarcoma patients JO - Oncol Rep VL - 31 ID - Song2014 ER - TY - JOUR AU - Tang, J. AU - Zhao, H. AU - Cai, H. AU - Wu, H. PY - 2015 DA - 2015// TI - Diagnostic and prognostic potentials of microRNA-27a in osteosarcoma JO - Biomed Pharmacother VL - 71 UR - https://doi.org/10.1016/j.biopha.2015.01.025 DO - 10.1016/j.biopha.2015.01.025 ID - Tang2015 ER - TY - JOUR AU - Tian, Y. AU - Fu, S. AU - Qiu, G. B. AU - Xu, Z. M. AU - Liu, N. AU - Zhang, X. W. PY - 2014 DA - 2014// TI - MicroRNA-27a promotes proliferation and suppresses apoptosis by targeting PLK2 in laryngeal carcinoma JO - BMC Cancer VL - 14 UR - https://doi.org/10.1186/1471-2407-14-678 DO - 10.1186/1471-2407-14-678 ID - Tian2014 ER - TY - JOUR AU - Li, J. AU - Wang, Y. AU - Song, Y. AU - Fu, Z. AU - Yu, W. PY - 2014 DA - 2014// TI - miR-27a regulates cisplatin resistance and metastasis by targeting RKIP in human lung adenocarcinoma cells JO - Mol Cancer VL - 13 UR - https://doi.org/10.1186/1476-4598-13-193 DO - 10.1186/1476-4598-13-193 ID - Li2014 ER - TY - JOUR AU - Xu, L. AU - Xiang, J. AU - Shen, J. AU - Zou, X. AU - Zhai, S. AU - Yin, Y. PY - 2013 DA - 2013// TI - Oncogenic microRNA-27a is a target for genistein in ovarian cancer cells JO - Anticancer Agents Med Chem VL - 13 UR - https://doi.org/10.2174/18715206113139990006 DO - 10.2174/18715206113139990006 ID - Xu2013 ER - TY - JOUR AU - Ajdarkosh, H. AU - Dadpay, M. AU - Yahaghi, E. AU - Pirzaman, E. R. AU - Fayyaz, A. F. AU - Darian, E. K. AU - Mokarizadeh, A. PY - 2015 DA - 2015// TI - Decrease expression and clinicopathological significance of miR-148a with poor survival in hepatocellular carcinoma tissues JO - Diagn Pathol VL - 10 UR - https://doi.org/10.1186/s13000-015-0371-4 DO - 10.1186/s13000-015-0371-4 ID - Ajdarkosh2015 ER -